Torrent and Zydus sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India
Ahmedabad, November 10, 2023, Torrent Pharmaceuticals Limited (“Torrent”), a specialty focussed global pharmaceutical company, and Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as “Zydus”) a discovery-driven, global lifesciences company, today announced that they have entered into a licensing and supply agreement to co-market Saroglitazar Mg for the treatment of Non-Alcoholic Steato Hepatitis (NASH) and Non-Alcoholic […]
